نتایج جستجو برای: sustained virological response

تعداد نتایج: 1045619  

2016
Hyun Woong Lee

Approximately 130 to 150 million people are chronically infected with hepatitis C virus (HCV) in the world. HCV infection is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). The existence of hepatitis C— originally identifiable only as a type of non-A, non-B hepatitis— was suggested in the 1970s and proven in 1989. In the treatment of chronic hepatitis C (...

Journal: :Acta gastro-enterologica Belgica 2010
H Van Vlierberghe M Adler B Bastens I Colle J Delwaide J Henrion Y Horsmans P Michielsen P Golstein J-P Mulkay W Van Steenbergen P Yap F Nevens A M Denys J-P Brasseur

BACKGROUND AND STUDY AIMS Large international clinical trials conducted in the past 5 years rapidly improved the treatment of chronic hepatitis C; however, it is unclear whether the advances seen in clinical trials are being paralleled by similar improvements in routine clinical practice. PegIntrust is a Belgian community-based trial evaluating the sustained virological response. PATIENTS AND...

Journal: :Digestion 2000
G Teuber T Berg R M Hoffmann L Leifeld M Lafrenz U Spengler G R Pape U Hopf S Zeuzem

BACKGROUND/AIMS Combination therapy with interferon-alpha (IFN-alpha) plus ribavirin is more efficacious than IFN-alpha monotherapy in previously untreated patients with chronic hepatitis C and patients with IFN-alpha relapse. Only limited data are available in IFN-alpha non-responders. In a multicenter trial we therefore evaluated the efficacy of combination therapy in IFN-alpha-resistant chro...

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2015
Bo Feng Rui-Feng Yang Hai-Ying Zhang Bi-Fen Luo Fan-Yun Kong Hui-Ying Rao Qian Jin Xu Cong Lai Wei

Response-guided therapy is of limited use in developing countries because hepatitis C virus RNA detection by sensitive molecular methods is time- and labor-consuming and expensive. We evaluated early predictive efficacy of serum hepatitis C virus core antigen kinetics on sustained virologic response in patients with genotype 1 hepatitis C virus during pegylated interferon plus ribavirin treatme...

Journal: :Alimentary pharmacology & therapeutics 2006
M K Chapko J A Dominitz

BACKGROUND Although the current standard of care for controlling anaemia and neutropenia during anti-viral therapy for hepatitis C is to use dose reduction of ribavirin and pegylated interferon, respectively, erythropoietin and granulocyte colony-stimulating factor are now being advocated as alternatives to dose reduction. AIM To determine the cost-effectiveness of erythropoietin and granuloc...

2014
Rushna Firdaus Aritra Biswas Kallol Saha Anirban Mukherjee Sujit Chaudhuri Alok Chandra Asokananda Konar Provash Chandra Sadhukhan

BACKGROUND AND AIMS Genetic polymorphisms near interleukin 28B gene are associated with spontaneous and treatment induced clearance of hepatitis C virus (HCV). Our objective was to evaluate the impact of interleukin 28B single nucleotide polymorphism (rs12979860, rs8099917) variability in HCV genotype 3 infected populations. METHODS 400 hepatitis C seroreactive patients from different populat...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008
Duncan Smith-Rohrberg Maru Robert Douglas Bruce Sanjay Basu Frederick L Altice

BACKGROUND More than one-third of people in the United States with hepatic C virus (HCV) infection pass through the correctional system annually. Data are lacking on outcomes of treatment with pegylated interferon plus ribavirin (PEG-RBV) in correctional settings. METHODS During 2002-2006, we analyzed patients in the Connecticut Department of Correction who received PEG-RBV. We assessed the r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید